Literature DB >> 2461166

Soluble dipeptidyl peptidase IV from terminal differentiated rat epidermal cells: purification and its activity on synthetic and natural peptides.

M Kikuchi1, K Fukuyama, W L Epstein.   

Abstract

In terminally differentiated epidermal cells dipeptidyl peptidase IV (EC 3.4.14.5) (DPP IV) is present mainly in a soluble form. We purified the enzyme from 2-day-old rat cornified cells to homogeneity by Sephadex G-200 and Mono-Q column chromatography and finally HPLC gel filtration on G3000SW. The enzyme was estimated to be Mr 190,000 by HPLC gel filtration and Mr 90,000 by sodium dodecyl sulfate-electrophoresis. The enzyme showed general properties reported for detergent-solubilized DPP IV from other tissues. It was Con A binding and almost completely inhibited by 1 mM diisopropyl fluorophosphate and Diprotin A. The pI was 5.6 and the pH optimum was 7.5. The specific activity for Gly-Pro-p-nitroanilide was 31.9 units/mg. HPLC analysis demonstrated the release of dipeptides of the N-terminal of substance P, beta-casomorphin, and their related peptides. A stoichiometric reaction of the enzyme on substance P was observed. The epidermal DPP IV had a Km of 0.3 mM and a kcat of 50.3 s-1 for substance P and the Km value decreased by shortening the peptide from the carboxyl-terminal amino acids. The enzyme hydrolyzed human and bovine beta-casomorphin with Km values of 0.025 and 0.05 mM, respectively. Shortening the bovine beta-casomorphin peptide chain did not affect enzyme affinity.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2461166     DOI: 10.1016/0003-9861(88)90268-8

Source DB:  PubMed          Journal:  Arch Biochem Biophys        ISSN: 0003-9861            Impact factor:   4.013


  5 in total

1.  Purification and characterization of barley dipeptidyl peptidase IV.

Authors:  A Davy; K K Thomsen; M A Juliano; L C Alves; I Svendsen; D J Simpson
Journal:  Plant Physiol       Date:  2000-02       Impact factor: 8.340

Review 2.  Dipeptidyl peptidase-4: a key player in chronic liver disease.

Authors:  Minoru Itou; Takumi Kawaguchi; Eitaro Taniguchi; Michio Sata
Journal:  World J Gastroenterol       Date:  2013-04-21       Impact factor: 5.742

Review 3.  Gut-Pancreas-Liver Axis as a Target for Treatment of NAFLD/NASH.

Authors:  Gianluca Svegliati-Baroni; Bárbara Patrício; Gessica Lioci; Maria Paula Macedo; Amalia Gastaldelli
Journal:  Int J Mol Sci       Date:  2020-08-13       Impact factor: 5.923

Review 4.  Gluten and FODMAPs Relationship with Mental Disorders: Systematic Review.

Authors:  Egoitz Aranburu; Silvia Matias; Edurne Simón; Idoia Larretxi; Olaia Martínez; María Ángeles Bustamante; María Del Pilar Fernández-Gil; Jonatan Miranda
Journal:  Nutrients       Date:  2021-05-31       Impact factor: 5.717

Review 5.  The opioid effects of gluten exorphins: asymptomatic celiac disease.

Authors:  Leo Pruimboom; Karin de Punder
Journal:  J Health Popul Nutr       Date:  2015-11-24       Impact factor: 2.000

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.